Navigation Links
Chimerix Commences CMX001 Open-Label Clinical Study for the Treatment of Patients With Life-Threatening or Serious dsDNA Viral Infections
Date:1/7/2011

s, including the more than 130 Emergency INDs requested by leading investigators," said Wendy Painter, M.D., M.P.H., Chief Medical Officer of Chimerix.  "The demand for CMX001 to treat life-threatening infections continues to grow among the clinical community, and we are extremely proud to provide CMX001 under this open-label study."

CMX001-350 Open-Label Study Design

The primary objective of the multicenter open-label study of CMX001 is to provide CMX001 to patients with immediately life-threatening or serious disease caused by any of 12 different viral infections resulting from dsDNA viruses. The open-label study is expected to enroll 200 infected adult and pediatric patients.  Critically-ill patients expected to enroll in this study in the highest numbers include immunocompromised patients suffering from a variety of dsDNA infections, particularly patients undergoing solid organ transplant or hematopoietic stem cell transplant.  However, the study is intended for any patient with a serious dsDNA viral disease for whom no satisfactory alternate therapy is available and who does not qualify for other CMX001 clinical studies.(1)

The study will evaluate the safety, tolerability and antiviral activity of CMX001.  Researchers will also evaluate the activity of CMX001 through changes in clinical signs and symptoms of infection.  Patients will receive CMX001 orally twice weekly for up to three months, and treatment may be extended for up to six months depending on the patient's clinical response.  Antiviral activity will be measured by changes in viral burden from baseline in an individual patient's condition and across all patients with a given dsDNA virus.  Drug pharmacokinetics and any potential signs of drug resistance will also be assessed.

The clinical design parameters of the CMX001-350 study were based in large part on Chimerix's experiences providing CMX001 to patients under investigator-held
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
2. Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
3. Chimerix to Present at Two Upcoming Investor Conferences
4. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
5. Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
6. Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
7. Chimerix to Present at 9th Annual BIO Investor Forum
8. Chimerix Reaffirms Its Commitment to CMX001 as a Medical Countermeasure for Smallpox and Broad-Spectrum Antiviral Agent
9. Chimerix to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
10. Chimerixs Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety and Tolerability
11. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Research and Markets ( ... "Cannulas Market by Product (Nasal, Arterial, Arthroscopy, ... Material (Plastic, Metal) & End Users (Hospitals, Ambulatory ... report to their offering. The global ... CAGR of 5.6% from 2015 to 2020 to ...
(Date:5/6/2015)... , May 6, 2015 In ... malaria and tuberculosis combined[1]. Approximately 40 percent of cancer cases ... the right treatment[3]. Together with Elekta, ministries of health in ... their radiation therapy infrastructures and save lives. More ... from radiation therapy[4] during the course of their disease, either ...
(Date:5/6/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/4fgrnh/asiapacific ) ... Internal Trauma Fixation Devices Market by Type & ... report to their offering. The ... to grow at a CAGR of 6.7% from ... rising incidences of road accidents, increasing aging population, ...
Breaking Medicine Technology:Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 3Elekta to bring cancer treatment to millions in Africa 2Elekta to bring cancer treatment to millions in Africa 3Elekta to bring cancer treatment to millions in Africa 4Asia-Pacific Internal Trauma Fixation Devices (Internal Trauma Fixation Plates, Screws, Rod Wires & Pins, Fusion Nails) Market 2015 2
(Date:5/6/2015)... North Vancouver, BC (PRWEB) May 06, 2015 ... leading colon hydrotherapy supplier, is excited to announce ... which will help reduce the industry’s carbon footprint ... These kits feature Eco-Flex™, the ... hydrotherapy. “This is a game-changer for hydrotherapists,” claims ...
(Date:5/6/2015)... 06, 2015 The Beryl Institute announces ... of Patient Experience Journal (PXJ), an international, open access, ... understanding and improving patient experience. The second volume of ... conversation globally, helps align the voices engaged and provides ... Published in association with The Beryl Institute, Volume 2, ...
(Date:5/6/2015)... Ohio (PRWEB) May 06, 2015 Animals make ... shows they are also good for your health. An Ohio ... today reports an increase he's seeing with health advantages of ... things happen. When it comes to pet ownership, there are ... improvements,” Dr. Scott Leffler of the Animal ...
(Date:5/6/2015)... 2015 Is Colorado’s legal cannabis industry ... the Centennial State will mark the 18-month milestone of ... adults. And while Colorado’s legal marijuana industry has been ... it’s also facing some new challenges. , For example, ... shortages, especially in the wake of last month’s “420” ...
(Date:5/6/2015)... Inversion Studios, a full-service training ... Pilates classes, provides personalized individual instruction and now ... its new Pilates Ring magic circle. , Inversion ... stronger, more centered and graceful, Inversion Studios and ... to healthy fitness through yoga and Pilates. With ...
Breaking Medicine News(10 mins):Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3
... age. But some female birds can slow the ticking ... to results of a study published online last week in ... less fertile as age takes its toll, says biologist Josh ... Carolina, and co-author of the Oikos paper. Older females ...
... TUESDAY, Jan. 18 (HealthDay News) -- Researchers report promising results ... of Alzheimer,s disease, potentially allowing doctors to try to treat ... blood tests could indicate higher risks of dementia later in ... not curable, and existing treatments only have limited effects. ...
... , WEDNESDAY, Jan. 19 (HealthDay News) -- Adults with ... increased risk of developing a common form of degenerative ... study says. "Lewy bodies" -- abnormal clumps of ... brain functioning -- are found in people with Parkinson,s ...
... HealthDay Reporter , TUESDAY, Jan. 18 (HealthDay ... that a controversial treatment for multiple sclerosis can help ... highly skeptical of the claims. The debate ... surgeon from Italy, published an intriguing study that suggested ...
... childhood may lead to premature loss of lung ... adulthood, researchers at Emory University School of Medicine ... severe asthma is important to help stem asthma ... January issue of the Journal of Allergy ...
... Health has been issued a US patent claiming a ... on their surfaces. The method, discovered by John Cambier, ... National Jewish Health, holds promise for treatment of B-cell ... lupus and rejection of organ transplants. This therapeutic approach ...
Cached Medicine News:Health News:Biological clock ticks slower for female birds who choose good mates 2Health News:Progress Reported in Predicting Alzheimer's 2Health News:Adult ADHD Often Precedes Certain Type of Dementia: Study 2Health News:Vein-Opening Treatment for MS Stirs Controversy 2Health News:Vein-Opening Treatment for MS Stirs Controversy 3Health News:Vein-Opening Treatment for MS Stirs Controversy 4Health News:Children with severe asthma experience premature loss of lung function during adolescence 2Health News:Patent awarded for method to dampen immune response 2
... The 7600 Oscillating Saw ... bone osteotomies, thanks to its ... The cutting head may be ... cutting in any plane and ...
... System is a battery powered orthopedic system ... innovative design features an all inclusive sterile ... the battery, motor and all electronics. The ... provides a truly reliable and high performing ...
... ApaPore is a synthetic ... is disease free, readily ... a highly controlled specification ... graft., ,Surgical applications include ...
... Tips offer a safe alternative to using ... for applications such as PCR(a), pipetting radioactive ... Tips are excellent for tissue culture, gel ... Tips prevent aerosol contaminants and liquids from ...
Medicine Products: